| Advice You |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Sales Management > Management: Becoming A Self Aware Leader |
|
Advice You - Management: Becoming A Self Aware Leader
To be a leader means not only to be in charge of others it also means to be in charge of one's self! Although this According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product may sound like an obvious statement you might not be surprised by how many so-called "leaders" behave as if they are ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in on automatic pilot. That is they are unconscious of the choices that they are making. What do I mean by unconscious lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. ? Well I'm referring to making choices that are driven by deeply held emotional factors that were largely learned f here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe om early life experiences. Such behaviors are often "imprinted" into one's nervous system as a result of failed or t d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro raumatic emotional experiences. When this happens to an individual they develop what I have termed "emotional landm ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc nes" (please see my article of the same name here in this ezine) that leave them prone to exhibiting self sabotaging easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi behaviors that they seemingly can't control. Examples might include such things as: being overly aggressive or con nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically rolling, getting angry, failing to share important information with colleagues, inability to communicate effectively and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ , a paranoid or secretive attitude towards others, inability to relax and work effectively with the team and so on. ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi To effectively lead others one must clear such negative habits from one's repertoire of behaviors. Otherwise it is c ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a ear that their leadership will be severely undermined. The result can spell disaster for an organization. In order dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod to clear such negative emotional landmines it becomes imperative for leaders to courageously enter into a phase of s cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin lf contemplation. That is: 1. Stop and accept there is a problem. 2. Accept that the problem is emotionally based. tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen 3. Accept that acknowledging this is a sign of strength and not weakness. 4. Have the courage to get help for the t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel problem. 5. Recognize that the problem is "in them" but is not necessarily them. 6. The problem, which consists of ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust the emotional landmine can be easily diffused and released. 7. That by doing so they will feel significantly empow y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products red and sure of their ability to be in charge of themselves and others in a successful manner. All of this can be a . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de chieved with a new modality called the Mind Resonance Process(TM) (MRP) that I administer over the telephone with ex elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip cutives internationally. To learn more about MRP kindly visit the web link below and book your no risk consultation tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Corporate Records - What to Keep Press Releases - Helping Raise Business Don't Manage All Customers the Same Way
|